Altre lingue BioHarvest Sciences Inc. Canadian Securities Exchange

Azioni

BHSC

CA13767B1013

Tempo differito Canadian Securities Exchange Altri mercati azionari 16:24:58 05/10/2021			Variaz. 5gg	Var. 1 gen.
0,35 ^CAD	+6,06%		-2,94%	+46,67%

30/04	BioHarvest Sciences Inc. riporta i risultati degli utili per l'intero anno terminato il 31 dicembre 2023	CI
16/04	BioHarvest Sciences Inc. annuncia il nuovo campus per il CDMO di sintesi botanica e l'espansione della capacità di produzione	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

BioHarvest Sciences to Host Corporate Update Call May 2 at 2:30 P.M. Eastern Time	01/05
BioHarvest Sciences Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	30/04
BioHarvest Sciences Reports Strong Financial Performance for 2023, Eyes Nasdaq Listing	30/04
BioHarvest Sciences Reports Fourth Quarter and Full Year 2023 Financial Results	30/04
BioHarvest Sciences secures new state of the art 80,0000 square foot manufacturing facility	18/04
BioHarvest Sciences Inc. Announces New Campus for Botanical Synthesis CDMO and Expansion of Manufacturing Capacity	16/04
BioHarvest Sciences Announces New Campus for Botanical Synthesis CDMO and Expansion of Manufacturing Capacity	16/04
BioHarvest Sciences adds key hires as company looks to ramp up CDMO Services Business Unit	27/03
BioHarvest Sciences Appoints Anna Tenstam as VP of Business Development, Cosmeceuticals and Injectables	21/03
BioHarvest Sciences to Participate in Benzinga Virtual Healthcare Summit 2024 on March 20, 2024	14/03
BioHarvest Sciences Announces New Strategic Hires for CDMO Services Business Unit	13/03
BioHarvest Sciences to Participate in iAccess Alpha Buyside Best Ideas Conference on March 12-13, 2024	07/03
BioHarvest Sciences to Host Corporate Update Discussing Launch of CDMO Business Unit on March 13 at 2:30 p.m. Eastern Time	29/02
BioHarvest Sciences Signs First Contracts with Two Industrial Customers to Develop Complex Molecules	26/02
BioHarvest Sciences Inc. Announces Launch of New Contract Development and Manufacturing Organization Business Unit	26/02
BioHarvest Sciences Inc. Signs First Contracts with Two Industrial Customers to Develop Complex Molecules Via Its Newly Launched Botanical Synthesis CDMO Business Unit	26/02
BioHarvest Sciences Signs First Contracts with Two Industrial Customers to Develop Complex Molecules via Its Newly Launched Botanical Synthesis CDMO Business Unit	26/02
BioHarvest Sciences Issues Clarification to February 15, 2024 News Release Announcing Engagement with IR Firm	20/02
BioHarvest Sciences Engages MZ Group to Lead Strategic Investor Relations and Shareholder Communications Program	15/02
BioHarvest Sciences to Present at the 2024 BIO CEO & Investor Conference	12/02

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue BioHarvest Sciences Inc. Canadian Securities Exchange

Azioni

BHSC

CA13767B1013

Altre lingue

Filtri